Overview of SGLT-2 inhibitors in T2DM management: current position & future promise
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- SGLT2 Inhibition, Diabetes and CVD: Where does this fit in CV risk management?HF & Diabetes: SGLT2 inhibition a paradigm shift?
John McMurray, MD
- SGLT2 Inhibition, Diabetes and CVD: Where does this fit in CV risk management?Challenging cardiovascular risk in diabetes: ready for a new approach?
John Deanfield, MD
